Director Appointment
4basebio PLC has appointed Mr. Cornel Chiriac as a Non-executive Director, effective immediately, bringing 25 years of investment and operational management experience, including a decade in deep tech and science venture capital. Mr. Chiriac, who currently serves as an investment director at M&G Investments’ Crossover Fund, previously co-founded 2050 Capital and has a track record of scaling ventures to multi-million-dollar exits. He holds no ordinary shares, options, or warrants in the Company. The CEO expressed confidence that Mr. Chiriac's strategic perspective will be valuable as 4basebio continues to grow its commercial business and execute its long-term strategy.
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
4basebio PLC (AIM: 4BB), a company pioneering an enzymatically-produced DNA technology serving the next generation genetic medicines markets, is pleased to announce the apppointent of Mr. Cornel Chiriac as Non-executive Director of the Company with immediate effect.
- Chiriac currently serves as an investment director at M&G Investments’ Crossover Fund, and brings 25 years of experience in investing and portfolio and operational management, with 10 years focused on deep tech and science venture capital.
Earlier in his career, Mr. Chiriac was a founding partner of 2050 Capital, a London-based deep tech and science venture capital firm, through which he holds a number of portfolio directorships. Prior to that, he built and scaled two ventures in the USA to multi-million-dollar exits, having begun his career as a strategy and deal consultant with L.E.K. Consulting. He holds an MBA from the University of Chicago Booth School of Business.
Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Mr. Corneliu (“
Cornel
”) Chiriac (aged 49):
| Current Directorships | Previous Directorships held in the past five years |
| 2050 Capital Limited | Elemente LLC |
| Autonomous Manufacturing Ltd | International Kilobar Association Ltd |
| Bit Bio Limited | The Naked Pharmacy Ltd |
Blue Elm Limited
Hadean Supercomputing Ltd
OSCPS Motion Sensing Inc
TriEye Limited
- Chiriac holds no Ordinary Shares, and no options or warrants over Ordinary Shares. There is no further information regarding Mr. Chiriac that is required to be disclosed under the AIM Rules.
- Amy Walker, CEO of the Company said: “
'I am delighted to welcome Cornel to the 4basebio Board following his involvement in the Company for the last two years representing M&G. His strategic perspective, thoughtful approach and strong understanding of scaling innovative technology businesses will be a valuable addition as we continue to grow our commercial business and execute our long-term strategy. I look forward to working with him as we build on our momentum and create further value for shareholders
.”
.
4372176_0.png
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.